Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

VITAMIN B1 AND ITS STATUS IN VEGETARIANS AND VEGANS

DOI: https://doi.org/10.29296/25877313-2023-05-03
Issue: 
5
Year: 
2023

R. Ranjit
Рeoples’ Friendship University of Russia (RUDN University) (Moscow, Russia)
ORCID: 0000-0002-4255-4197
A.V. Galchenko
Federal Research Centre for Nutrition, Biotechnology and Food Safety (Moscow, Russia)
E-mail: gav.jina@gmail.com; ORCID: 0000-0001-7286-5044

Vitamin B1 is a water-soluble vitamin whose alternative name is thiamine or thiamin. The metabolically active form of vitamin B1 is thiamin diphos-phate, also known as thiamin pyrophosphate. Thiamin diphosphate is a coenzyme in the pyruvate dehydrogenase complex and in the Krebs cycle. Thus, it is directly involved in catabolism. In addition, vitamin B1 also takes part in the pentose phosphate shunt, which contributes to the synthesis of nucleotides and their derivatives. Similarly, thiamin diphosphate plays an important role in myelin synthesis, amino acid metabolism, and the metabo-lism of neurotransmitters and hormones. There is also evidence for its direct regulation of ion channel activity. Lack of vitamin B1 affects all organs and tissues, but the earliest manifestations of its deficiency are found in the nervous system. There are several reasons for this. Firstly, the nervous tissue is extremely and continuously dependent on glucose oxidation, which can be disrupted in case of insuffi-ciency of the pyruvate dehydrogenase complex. Secondly, myelin production is interrupted. Thirdly, there is an imbalance of neurotransmitters. The fourth reason is the high activity of transmembrane ion-exchange processes in the nervous tissue. All these lead to damage to the central and periph-eral nervous system and, in severe cases, the development of beriberi or Wernicke-Korsakoff syndrome. B1 hypervitaminosis is an unlikely event. The hydrophilic thiamin diphosphate is rapidly excreted through the urine with an increase in its serum con-centrations. In addition, the intake of large amounts of thiamin with food significantly reduces its intestinal absorption. As thiamin is relatively safe even in high quantities, the high vitamin B1 dose is used to treat symptoms of chronic cluster headaches and some neurodegenerative diseases. Thiamin is quite evenly distributed in both animal- and plant-derived products. Its highest concentrations are found in the outer layer of cereals, leg-umes, seeds, or nuts. As a result, most studies show that thiamin intake is higher in vegans and vegetarians than in omnivores. But, with regard to the status of vitamin B1, not everything is so crystal clear. There are not many studies done on this topic to date. The lack of general consensus on a single accepted methodology for assessing the status of vitamin B1 seems to be the main hurdle. Although most of the data indicate a better supply of vitamin B1 in vegans and vegetarians, further research and standardization of methods are still needed.

Keywords: 
thiamin
thiamin diphosphate (TDP)
thiamin pyrophosphate (TPP)
pyruvate dehydrogenase complex (PDC)
pentose phosphate shunt
myelin
neuropa-thy
beriberi
Wernicke-Korsakoff syndrome
plant-based.

References: 
  1. Coates P.M. Encyclopedia of dietary supplements. Informa Healthcare; 2010. 898 p.
  2. Ross A.C., Caballero B.H., Cousins R.J., Tucker K.L., Ziegler T.R. Modern nutrition in health and disease. 11th ed. Wolters Kluwer Health, Lippincott Williams & Wilkins; 2014. 1616 p.
  3. Lu J., Frank E.L. Rapid HPLC measurement of thiamine and its phosphate esters in whole blood. Clin Chem. 2008; 54(5):901–6.
  4. Ihara H., Hirano A., Wang L., Okada M., Hashizume N. Reference values for whole blood thiamine and thiamine phosphate esters in Japanese adults. J Anal Bio-Science. 2005; 28(3):241–6.
  5. Nabokina S.M., Said H.M. A high-affinity and specific carrier-mediated mechanism for uptake of thiamine pyrophos-phate by human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2012; 303(3).
  6. Das M.L., Koike M., Reed L.J. On the role of thiamine pyrophosphate in oxidative decarboxylation of α-keto acids. Proc. Natl. Acad. Sci. USA. 1961; 47(6):759.
  7. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evidence-based Complement Altern. Med. 2006; 3(1):49–59.
  8. Wendołowicz A., Stefańska E., Ostrowska L. Influence of selected dietary components on the functioning of the human nervous system. Rocz. Panstw. Zakl. Hig. 2018; 69(1):15–21.
  9. Singleton. C., Martin P. Molecular mechanisms of thiamine utilization. Curr. Mol. Med. 2001; 1(2):197–207.
  10. Sriram K., Manzanares W., Joseph K. Thiamine in nutrition therapy. Nutr. Clin. Pract. 2012; 27(1):41–50.
  11. Beltramo E., Berrone E., Tarallo S., Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabo-lism and relevance in the prevention of diabetic compli-cations. Acta Diabetol. 2008; 45(3):131–41.
  12. Martin P.R., Singleton C.K., Hiller-Sturmhöfel S. The Role of Thiamine Deficiency in Alcoholic Brain Disease. Alcohol Res. Heal. 2003; 27(2):142.
  13. Isenberg-Grzeda E., Kutner H.E., Nicolson S.E. Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics. 2012; 53(6):507–16.
  14. Ba A. Metabolic and structural role of thiamine in nervous tissues. Cell. Mol. Neurobiol. 2008; 28(7):923–31.
  15. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Panto-thenic Acid, Biotin, and Choline. Washington (DC): National Academies Press (US); 1998.
  16. Erdman J.W., MacDonald I., Zeisel S.H. Present knowledge in nutrition. International Life Sciences Institute; 2012. 1305 p.
  17. Agabio R. Thiamine administration in alcohol-dependent patients. Alcohol Alcohol. 2005; 40(2):155–6.
  18. Thomson A.D., Marshall E.J. The natural history and patho-physiology of Wernicke’s encephalopathy and Korsakoff’s psychosis. Alcohol Alcohol. 2006; 41(2):151–8.
  19. Thomson A.D., Guerrini I., Marshall E.J. The evolution and treatment of Korsakoff’s syndrome out of sight, out of mind? Neuropsychol. Rev. 2012; 22(2):81–92.
  20. Kopelman M.D., Thomson A.D., Guerrini I., Marshall E.J. The korsakoff syndrome: Clinical aspects, psychology and treatment. Alcohol Alcohol. 2009; 44(2):148–54.
  21. Tallaksen C.M.E., Taubøll E. Excitatory effect of thiamin on CA1 pyramidal neurones in rat hippocampal slices in vitro. Eur. J. Neurol. 2000; 7(6):693–8.
  22. Oliveira F.A., Galan D.T., Ribeiro A.M., Santos Cruz J. Thiamine deficiency during pregnancy leads to cerebellar neuronal death in rat offspring: role of voltage-dependent K+ channels. Brain. Res. 2007; 1134(1):79–86.
  23. Goldberg D.J., Begenisich T.B., Cooper J.R. Effects of thi-amine antagonists on nerve conduction. II. Voltage clamp ex-periments with antimetabolites. J Neurobiol. 1975; 6(5):453–62.
  24. Claus D., Eggers R., Warecka K., Neundörfer B. Thiamine deficiency and nervous system function disturbances. Eur. Arch. Psychiatry Neurol. Sci. 1985; 234(6):390–4.
  25. Trostler N., Guggenheim K., Havivi E., Sklan D. Effect of thiamine deficiency in pregnant and lactating rats on the brain of their offspring. Nutr. Metab. 1977; 21(5):294–304.
  26. Sanjeeva Reddy T., Ramakrishnan C.V. Effects of maternal thiamine deficiency on the lipid composition of rat whole brain, gray matter and white matter. Neurochem. Int. 1982; 4(6):495–9.
  27. Friedemann T.E., Kmieciak T.C. The absorption, destruction, and excretion of orally administered thiamin by human subjects. Gastroenterology. 1948; 11(1):100–14.
  28. Costantini A., Pala M.I., Grossi E., et al. Long-Term Tre-atment with High-Dose Thiamine in Parkinson Disease: An Open-Label Pilot Study. J. Altern. Complement. Med. 2015; 21(12):740–7.
  29. Costantini A., Giorgi R., D’Agostino S., Pala M.I. Case Report: High-dose thiamine improves the symptoms of Fri-edreich’s ataxia. BMJ Case Rep. 2013; 2013:bcr2013009424.
  30. Antonio C., Massimo T., Gianpaolo Z., Immacolata P.M., Erika T. Oral High-Dose Thiamine Improves the Symptoms of Chronic Cluster Headache. Case Rep Neurol Med. 2018; 2018:1–5.
  31. U.S. Department of Agriculture, Agricultural Research Service. 2019.
  32. FDA. Food Labeling Guide. 2020.
  33. State sanitary and epidemiological regulation of the Russian Federation, food hygiene and balanced diet, Guidelines 2.3.1.0253-21. Norms of physiological needs for energy and nutrients for various groups of the population of the Russian Federation. Moscow; 2021 Jul.
  34. Heymsfield S.B., Baumgartner R.N. Body Composition And Anthropometry. In: Modern Nutrition in Health and Disease. 2007. p. 635–46.
  35. D-A-CH (German Society for Nutrition, Austrian Society for Nutrition S.S. for N. Reference values for nutrient intake. Bonn, Germany.; 2015.
  36. Nordic Council of Ministers. Nordic Nutrition Recommen-dations. Integrating nutrition and physical activity. Copen-hagen, Denmark; 2014 Mar.
  37. WHO/FAO (World Health Organization/Food and Agri-culture Organization of the United Nations). Vitamin and mi-neral requirements in human nutrition: report of a joint FAO/WHO expert consultation. Bangkok, Thailand; 2004.
  38. Afssa (Agence francaise de securite sanitaire des aliments). Apports nutritionnels conseilles pour la population francaise. Paris, France; 2001.
  39. Health Council of the Netherlands. Dietary reference intakes: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic acid, and biotin. 2000.
  40. SCF (Scientific Committee for Food). Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, 31st Series. Luxembourg; 1993.
  41. DH (Department of Health). Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London, UK; 1991.
  42. Janelle K.C., Barr S.I. Nutrient Intakes and Eating Behavior see of Vegetarian and Nonvegetarian Women. J. Am. Diet. Assoc. 1995; 95(2):180–9.
  43. Sobiecki J.G., Appleby P.N., Bradbury K.E., Key T.J. High compliance with dietary recommendations in a cohort of meat eaters, fish eaters, vegetarians, and vegans: Results from the European Prospective Investigation into Cancer and Nutri-tion-Oxford study. Nutr Res. 2016; 36(5):464–77.
  44. Draper A., Lewis J., Malhotra N., Wheeler L.E. The energy and nutrient intakes of different types of vegetarian: a case for supplements? Br J Nutr. 1993; 69(1):3–19.
  45. Davey G.K., Spencer E.A., Appleby P.N., Allen N.E., Knox K.H., Key T.J. EPIC–Oxford:lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK. Public Health Nutr. 2003; 6(3):259–68.
  46. Shultz T.D., Leklem J.E. Vitamin B-6 status and bio-availability in vegetarian women. Am. J. Clin. Nutr. 1987; 46(4):647–51.
  47. Majchrzak D., Singer I., Männer M., et al. B-vitamin status and concentrations of homocysteine in Austrian omnivores, vegetarians and vegans. Ann. Nutr. Metab. 2007; 50(6):485–91.
  48. Gorbachev D.O., Sazonova O.V, Gilmiyarova F.N., et al. Characteristics of the nutritional status of vegetarians. Profil Meditsina. 2018; 21(3):51–6.
  49. Haddad E.H., Berk L.S., Kettering J.D., Hubbard R.W., Peters W.R. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am. J. Clin. Nutr. 1999; 70(3 Suppl):586S-593S.
  50. Elorinne A.L., Alfthan G., Erlund I., et al. Food and nutrient intake and nutritional status of Finnish vegans and non-vege-tarians. PLoS One. 2016; 11(2):e0148235.
  51. Kristensen N.B., Madsen M.L., Hansen T.H., et al. Intake of macro- and micronutrients in Danish vegans. Nutr. J. 2015; 14:115.
  52. Larsson C.L., Johansson G.K. Dietary intake and nutritional status of young vegans and omnivores in Sweden. Am. J. Clin. Nutr. 2002; 76(1):100–6.
  53. Schüpbach R., Wegmüller R., Berguerand C., Bui M., Herter-Aeberli I. Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland. Eur. J. Nutr. 2017; 56(1):283–93.
  54. Weikert C., Trefflich I., Menzel J., et al. Vitamin and Mineral Status in a Vegan Diet. Dtsch Arztebl Int. 2020; 117(35–36):575–582.
  55. Fallon N., Dillon S.A. Low Intakes of Iodine and Selenium Amongst Vegan and Vegetarian Women Highlight a Potential Nutritional Vulnerability. Front. Nutr. 2020; 7:72.
  56. Kowalska K., Brodowski J., Pokorska-Niewiada K., Szczuko M. The Change in the Content of Nutrients in Diets Eliminating Products of Animal Origin in Comparison to a Regular Diet from the Area of Middle-Eastern Europe. Nutrients. 2020; 12(10):2986.
  57. Blaurock J., Kaiser B., Stelzl T., et al. Dietary Quality in Vegetarian and Omnivorous Female Students in Germany: A Retrospective Study. Int. J. Environ. Res. Public Health. 2021; 18(4):1888.
  58. Millet P., Guilland J.C., Fuchs F., Klepping J. Nutrient intake and vitamin status of healthy French vegetarians and nonvegetarians. Am. J. Clin. Nutr. 1989; 50(4):718–27.
  59. Vudhivai N., Ali A., Pongpaew P., et al. Vitamin B1, B2 and B6 status of vegetarians. J. Med. Assoc. Thail. 1991; 74(10):465–70.